chr15-79970791-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000267953.4(BCL2A1):c.329C>T(p.Pro110Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000849 in 1,614,010 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P110S) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000267953.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BCL2A1 | NM_004049.4 | c.329C>T | p.Pro110Leu | missense_variant | 1/2 | ENST00000267953.4 | NP_004040.1 | |
BCL2A1 | NM_001114735.2 | c.329C>T | p.Pro110Leu | missense_variant | 1/3 | NP_001108207.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BCL2A1 | ENST00000267953.4 | c.329C>T | p.Pro110Leu | missense_variant | 1/2 | 1 | NM_004049.4 | ENSP00000267953 | P1 | |
BCL2A1 | ENST00000335661.6 | c.329C>T | p.Pro110Leu | missense_variant | 1/3 | 1 | ENSP00000335250 | |||
BCL2A1 | ENST00000677151.1 | c.329C>T | p.Pro110Leu | missense_variant | 1/1 | ENSP00000504466 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152146Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251278Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135834
GnomAD4 exome AF: 0.0000882 AC: 129AN: 1461864Hom.: 0 Cov.: 30 AF XY: 0.0000921 AC XY: 67AN XY: 727228
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152146Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74316
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 20, 2021 | The c.329C>T (p.P110L) alteration is located in exon 1 (coding exon 1) of the BCL2A1 gene. This alteration results from a C to T substitution at nucleotide position 329, causing the proline (P) at amino acid position 110 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at